1. Home
  2. GBIO vs NVFY Comparison

GBIO vs NVFY Comparison

Compare GBIO & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • NVFY
  • Stock Information
  • Founded
  • GBIO 2016
  • NVFY 2003
  • Country
  • GBIO United States
  • NVFY United States
  • Employees
  • GBIO N/A
  • NVFY N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • NVFY Home Furnishings
  • Sector
  • GBIO Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • GBIO 29.5M
  • NVFY 25.5M
  • IPO Year
  • GBIO 2020
  • NVFY N/A
  • Fundamental
  • Price
  • GBIO $6.00
  • NVFY $1.78
  • Analyst Decision
  • GBIO Buy
  • NVFY
  • Analyst Count
  • GBIO 4
  • NVFY 0
  • Target Price
  • GBIO $10.67
  • NVFY N/A
  • AVG Volume (30 Days)
  • GBIO 792.1K
  • NVFY 634.0K
  • Earning Date
  • GBIO 08-12-2025
  • NVFY 08-14-2025
  • Dividend Yield
  • GBIO N/A
  • NVFY N/A
  • EPS Growth
  • GBIO N/A
  • NVFY N/A
  • EPS
  • GBIO N/A
  • NVFY N/A
  • Revenue
  • GBIO $21,230,000.00
  • NVFY $9,813,990.00
  • Revenue This Year
  • GBIO N/A
  • NVFY N/A
  • Revenue Next Year
  • GBIO N/A
  • NVFY N/A
  • P/E Ratio
  • GBIO N/A
  • NVFY N/A
  • Revenue Growth
  • GBIO 61.15
  • NVFY N/A
  • 52 Week Low
  • GBIO $3.00
  • NVFY $0.39
  • 52 Week High
  • GBIO $29.40
  • NVFY $3.59
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 57.46
  • NVFY 45.39
  • Support Level
  • GBIO $5.91
  • NVFY $1.56
  • Resistance Level
  • GBIO $6.48
  • NVFY $2.09
  • Average True Range (ATR)
  • GBIO 0.50
  • NVFY 0.23
  • MACD
  • GBIO -0.03
  • NVFY -0.01
  • Stochastic Oscillator
  • GBIO 68.12
  • NVFY 37.37

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: